Batra SK - Search Results

1

New promising drug targets in cancer- and metastasis-initiating cells.

Mimeault M, Batra SK. Mimeault M, et al. Among authors: batra sk. Drug Discov Today. 2010 May;15(9-10):354-64. doi: 10.1016/j.drudis.2010.03.009. Epub 2010 Mar 23. Drug Discov Today. 2010. PMID: 20338259 Free PMC article. Review.

2

New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.

Mimeault M, Bonenfant D, Batra SK. Mimeault M, et al. Among authors: batra sk. Skin Pharmacol Physiol. 2004 Jul-Aug;17(4):153-66. doi: 10.1159/000078818. Skin Pharmacol Physiol. 2004. PMID: 15258446 Review.

3

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.

Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Among authors: batra sk. Int J Cancer. 2006 Feb 15;118(4):1022-31. doi: 10.1002/ijc.21440. Int J Cancer. 2006. PMID: 16108016

4

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Mimeault M, Batra SK. Mimeault M, et al. Among authors: batra sk. Carcinogenesis. 2006 Jan;27(1):1-22. doi: 10.1093/carcin/bgi229. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195239 Review.

5

Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.

Mimeault M, Brand RE, Sasson AA, Batra SK. Mimeault M, et al. Among authors: batra sk. Pancreas. 2005 Nov;31(4):301-16. doi: 10.1097/01.mpa.0000175893.04660.1b. Pancreas. 2005. PMID: 16258363 Review.

6

Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Among authors: batra sk. Stem Cells. 2006 Nov;24(11):2319-45. doi: 10.1634/stemcells.2006-0066. Epub 2006 Jun 22. Stem Cells. 2006. PMID: 16794264 Review.

7

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Among authors: batra sk. Int J Cancer. 2007 Jan 1;120(1):160-9. doi: 10.1002/ijc.22268. Int J Cancer. 2007. PMID: 17013895

8

Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.

Mimeault M, Batra SK. Mimeault M, et al. Among authors: batra sk. Cancer Metastasis Rev. 2007 Mar;26(1):203-14. doi: 10.1007/s10555-007-9052-4. Cancer Metastasis Rev. 2007. PMID: 17273942 Review.

9

Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Among authors: batra sk. Ann Oncol. 2007 Oct;18(10):1605-19. doi: 10.1093/annonc/mdm070. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355951 Free article. Review.

10

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.

Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Among authors: batra sk. Mol Cancer Ther. 2007 Mar;6(3):967-78. doi: 10.1158/1535-7163.MCT-06-0648. Mol Cancer Ther. 2007. PMID: 17363490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

662 results

Search Page

Filters